TrialAnnals of surgical oncology2022

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

Martha E Teke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.